S&P, Nasdaq Rise as Tech Rebounds Ahead of Earnings, Data | The Close 2/9/2026

Watch on YouTube ↗  |  February 09, 2026 at 23:50  |  1:29:49  |  Bloomberg Markets
Speakers
Andrew Slimmon — Senior Portfolio Manager, Morgan Stanley Investment Management
Dan Towriss — CEO, Cadillac Formula 1
Rajesh Kumar — Senior Global Life Science and Healthcare Analyst, HSBC
Jeff Currie — CSO Energy Pathways, Carlyle Group
Norah Mulinda — Market Reporter, Bloomberg
Kristina Hooper — Chief Global Market Strategist, Invesco
Robert Schiffman — Credit Analyst, Bloomberg Intelligence
Matt Miller — Anchor, Bloomberg
Michelle Meyer — Chief Economist, Mastercard Economics Institute
Mark Levine — New York City Comptroller
Adam Richman — Co-founder and Co-CEO, Medium Rare
Rasheeda Liberty — Founder, Lady Lib Sports & Entertainment
Lawrence Stroll — Owner, Aston Martin Aramco Formula One Team
Carol Massar — Anchor, Bloomberg
Katie Greifeld — Anchor, Bloomberg
Tim Stenovec — Anchor/Co-Host, Bloomberg TV & Radio

Summary

Stocks closed higher as tech rebounded, with market breadth continuing to improve ahead of key earnings and economic data. Guests debated whether the broadening rally is sustainable, while commodities strategist Jeff Currie argued a new commodity supercycle is beginning and Kristina Hooper stayed cautious on U.S. equities but favored Europe. Bond demand for AI-related debt and a 100-year Alphabet deal were also in focus, alongside Novo Nordisk's lawsuit against Hims & Hers.

  • U.S. stocks rose, led by tech, while equal-weight breadth continued to improve.
  • Andrew Slimmon saw broadening as healthy but warned of late-cycle speculative risk.
  • Jeff Currie made a bullish case for oil, copper, natural gas, and the old economy.
  • Kristina Hooper was cautious on U.S. equities but favored European credit and equities.
  • Robert Schiffman said AI-related corporate bond demand remains very strong.
  • Novo Nordisk sued Hims & Hers, pressuring HIMS and highlighting obesity-drug competition.
  • New York City's comptroller warned of a large structural budget gap.
  • Formula 1, Super Bowl events, and other non-market topics rounded out the show.
Ideas
Andrew Slimmon Senior Portfolio Manager, Morgan Stanley Investment Management 3:25
Favor equal-weight S&P on broadening.
He favors the broadening of the market because more stocks are participating: Q4 earnings beat rates improved versus earlier quarters, the yield curve is steepening and lowering New York Fed recession probability, and mega-cap margins face pressure as capex and compensation rise. This supports the S&P 493 and equal-weight S&P 500 versus the cap-weighted index.
Andrew Slimmon Senior Portfolio Manager, Morgan Stanley Investment Management 5:35
Avoid unprofitable tech as speculation flushes.
He warns that late-cycle rallies in non-profitable tech are speculative and tend to get walloped, as happened last week; he sees risk of a blowoff stage but views the market self-correcting as healthy, so these speculative tech names should be avoided.
Andrew Slimmon Senior Portfolio Manager, Morgan Stanley Investment Management 7:03
Wait and see on capex-heavy hyperscalers.
The largest hyperscalers are no longer reliable cash-rich value-like growth stocks; they are spending heavily on capex and buybacks, which pressures free cash flow and balance sheets and can cause the market to de-rate them. He would avoid a big new allocation and wait for more clarity.
Dan Towriss CEO, Cadillac Formula 1 15:32
Cadillac product cycle supports GM share gains.
Cadillac's product lineup is strong enough to support market-share upside, and entering Formula 1 with a Super Bowl commercial can broaden the brand and amplify that momentum for General Motors' Cadillac brand.
Rajesh Kumar Senior Global Life Science and Healthcare Analyst, HSBC 20:33
Lilly better positioned than Novo.
Eli Lilly has a second-market advantage with better labels and launch pricing, and has guided to about 25% growth next year versus Novo Nordisk's roughly 9% decline. Both face U.S. pricing pressure, but Novo's exposure to Wegovy generics and the need to reinvent next-generation drugs make it less attractive.
Rajesh Kumar Senior Global Life Science and Healthcare Analyst, HSBC 20:33
Lilly better positioned than Novo.
Eli Lilly has a second-market advantage with better labels and launch pricing, and has guided to about 25% growth next year versus Novo Nordisk's roughly 9% decline. Both face U.S. pricing pressure, but Novo's exposure to Wegovy generics and the need to reinvent next-generation drugs make it less attractive.
Jeff Currie CSO Energy Pathways, Carlyle Group 24:18
Oil glut is a myth; stay long.
The widely expected oil glut has not materialized; there have been substantial draws, sanctioned barrels cannot reach the market, a 250 million-barrel speculative short is unwinding, geopolitical risk is rising, and the market remains underinvested. He sees upside for oil.
Jeff Currie CSO Energy Pathways, Carlyle Group 25:40
Commodity supercycle beginning on underinvestment.
He sees a new commodity supercycle because oil and metals are substantially underinvested, OPEC's supply surge ends this year, refinery and mine investment is lacking, and policy-driven demand plus supply constraints will keep markets tight.
Jeff Currie CSO Energy Pathways, Carlyle Group 27:10
Copper structurally short; demand and hoarding.
Copper's resilience despite a selloff signals a structurally short market; geopolitical uncertainty encourages hoarding, the U.S. is hoarding metals, and data-center, grid, and transformer demand plus underinvestment support copper.
Jeff Currie CSO Energy Pathways, Carlyle Group 27:57
Rotate from tech into old economy.
He calls for a rotation out of asset-light tech into the asset-heavy old economy: hyperscalers are becoming asset-heavy, supply constraints bind, and capital must flow to energy, metals and mining, and commodities. He cites Nasdaq down 9% while metals and mining rose 25% and energy rose 22%.
Jeff Currie CSO Energy Pathways, Carlyle Group 27:57
Rotate from tech into old economy.
He calls for a rotation out of asset-light tech into the asset-heavy old economy: hyperscalers are becoming asset-heavy, supply constraints bind, and capital must flow to energy, metals and mining, and commodities. He cites Nasdaq down 9% while metals and mining rose 25% and energy rose 22%.
Jeff Currie CSO Energy Pathways, Carlyle Group 29:21
Natural gas benefits from AI power demand.
Hyperscalers are investing hundreds of billions in power-hungry data centers, and producing that power in the U.S. requires natural gas; supply constraints and underinvestment should support natural gas.
Norah Mulinda Market Reporter, Bloomberg 33:00
Kroger new CEO can modernize operations.
Kroger shares are rallying because new CEO Greg Foran, former Walmart CEO, is expected to modernize operations and digital commerce, address Kroger's lag versus Amazon and Walmart, and end uncertainty after the prior CEO's departure; investors see him as a transformational outsider.
Kristina Hooper Chief Global Market Strategist, Invesco 37:28
Cautious U.S. stocks on high valuations.
She is cautious on U.S. stocks because valuations remain high, the drivers of the selloff have not gone away, a hawkish Fed and balance-sheet reduction could hurt equities, and AI winners and losers are uncertain. She advises diversification and preparing for further selloffs.
Kristina Hooper Chief Global Market Strategist, Invesco 39:04
Long-end government bonds at risk.
She sees pressure for long-end yields to move higher, starting with Japan and spreading via fiscal deficits and bond vigilantes; long-duration government bonds are at risk.
Kristina Hooper Chief Global Market Strategist, Invesco 40:04
European IG and high-yield credit attractive.
For bondholders, she sees opportunities in investment-grade and high-yield credit, specifically in Europe, where Germany can increase fiscal deficits productively and markets may treat it differently from more indebted economies.
Kristina Hooper Chief Global Market Strategist, Invesco 40:57
European and German equities to outperform.
She likes European and German equities because valuations are attractive and higher fiscal spending on defense and infrastructure provides a catalyst with a higher multiplier than tax cuts; she expects them to continue outperforming the U.S., pointing to positive German factory orders.
Kristina Hooper Chief Global Market Strategist, Invesco 42:16
Big Tech AI capex faces funding risk.
Big tech's shift to bond funding for AI capex changes her view of them as equity investments; she questions how much AI capex will be tolerated, especially if data centers become obsolete in 15 years, and whether investors will comfortably buy 100-year bonds.
Robert Schiffman Credit Analyst, Bloomberg Intelligence 66:14
Bullish AI corporate bonds on strong demand.
He is very bullish on AI-related corporate credit: bondholders are not worried about an AI bubble, capex guidance has risen, and massive order books like Oracle's show strong demand. The 100-year Alphabet bond also shows long-dated demand from insurers, and he argues the bond market is telling equity investors to calm down.
Up Next

This Bloomberg Markets video, published February 09, 2026, features Andrew Slimmon, Dan Towriss, Rajesh Kumar, Jeff Currie, Norah Mulinda, Kristina Hooper, Robert Schiffman discussing S&P 493, RSP, Unprofitable tech stocks, SKYY, GM, LLY, NVO, WTI, DBC, COPPER, XME, XLE, QQQ, UNG, KR, SPY, Long-end government bonds, European investment-grade credit, European high-yield credit, VGK, EZU, XLK, AI-related corporate bonds, Alphabet 100-year bonds. 19 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Andrew Slimmon, Dan Towriss, Rajesh Kumar, Jeff Currie, Norah Mulinda, Kristina Hooper, Robert Schiffman  · Tickers: S&P 493, RSP, Unprofitable tech stocks, SKYY, GM, LLY, NVO, WTI, DBC, COPPER, XME, XLE, QQQ, UNG, KR, SPY, Long-end government bonds, European investment-grade credit, European high-yield credit, VGK, EZU, XLK, AI-related corporate bonds, Alphabet 100-year bonds